Key Insights

Highlights

Success Rate

55% trial completion

Clinical Risk Assessment

Based on trial outcomes

High Risk

Score: 60/100

Termination Rate

15.2%

5 terminated out of 33 trials

Success Rate

54.5%

-32.0% vs benchmark

Late-Stage Pipeline

9%

3 trials in Phase 3/4

Results Transparency

100%

6 of 6 completed with results

Key Signals

6 with results55% success

Data Visualizations

Phase Distribution

29Total
Not Applicable (12)
Early P 1 (1)
P 1 (4)
P 2 (9)
P 3 (3)

Trial Status

Active Not Recruiting9
Recruiting8
Completed6
Terminated5
Withdrawn5

Trial Success Rate

54.5%

Benchmark: 86.5%

Based on 6 completed trials

Clinical Trials (33)

Showing 20 of 20 trials
NCT04214262Phase 3Active Not Recruiting

Testing the Addition of the Drug Atezolizumab to the Usual Radiation Treatment for Patients With Early Non-small Cell Lung Cancer

NCT04430725Active Not Recruiting

Microwave Ablation or Wedge Resection for the Treatment of Lung, Sarcoma and Colorectal Lesions, ALLUME Study

NCT03811002Phase 3Active Not Recruiting

Testing the Addition of a New Immunotherapy Drug, Atezolizumab (MPDL3280A), to the Usual Chemoradiation (CRT) Therapy Treatment for Limited Stage Small Cell Lung Cancer (LS-SCLC)

NCT04183218Completed

Characterizing Chemo-Radiotherapy Treatment-Related Cardiac Changes

NCT04789681Phase 2Recruiting

Canakinumab for the Prevention of Lung Cancer, the Can-Prevent-Lung Trial

NCT03110978Phase 2Active Not Recruiting

Stereotactic Body Radiation Therapy With or Without Nivolumab in Treating Patients With Stage I-IIA or Recurrent Non-small Cell Lung Cancer

NCT03634241Phase 2Completed

Pembrolizumab in Preventing Lung Cancer in Patients With Stage I-II Non-Small Cell Lung Cancer or High-Risk Pulmonary Nodules, the IMPRINT-Lung Study

NCT03948100Not ApplicableRecruiting

Dyadic Yoga Intervention in Improving Physical Performance and Quality of Life in Patients With Stage I-IV Non-small Cell Lung or Esophageal Cancer Undergoing Radiotherapy and Their Caregivers

NCT03731585Not ApplicableActive Not Recruiting

Online Psychosocial Intervention in Improving Social Well-Being and Support in Women With Stage I-IV Non-small Cell Lung Cancer Undergoing Treatment

NCT03939481Active Not Recruiting

Treatment Effects on Development of Chemotherapy-Induced Peripheral Neuropathy in Patients With Cancer

NCT06869447Not ApplicableRecruiting

New York Better Breathing Study

NCT04505267Phase 1Active Not Recruiting

NBTXR3 and Radiation Therapy for the Treatment of Inoperable Recurrent Non-small Cell Lung Cancer

NCT03819296Phase 1Recruiting

Role of Gut Microbiome and Fecal Transplant on Medication-Induced GI Complications in Patients With Cancer

NCT04428905Phase 3Active Not Recruiting

Self-Management Survivorship Care in Stage I-III Non-small Cell Lung Cancer or Colorectal Cancer

NCT05502523Not ApplicableRecruiting

The Impact of Surgical Technique on Circulating Tumor DNA in Stage I-III Non-Small Cell Lung Cancer

NCT05292521Not ApplicableRecruiting

Quality of Life Intervention to Inform Patient Decision-Making in Early-Stage Lung Cancer

NCT05802186Not ApplicableRecruiting

Stereotactic Body Radiation Therapy Planning With Artificial Intelligence-Directed Dose Recommendation for Treatment of Primary or Metastatic Lung Tumors, RAD-AI Study

NCT04067830Phase 2RecruitingPrimary

Respiratory Muscle Training Before Surgery in Preventing Lung Complications in Patients With Stage I-IIIB Lung Cancer

NCT04946279Not ApplicableActive Not Recruiting

Decision Aid for the Improvement of Decision-Making in Patients With Non-small Cell Lung Cancer

NCT04987281Phase 2Withdrawn

Robotic Bronchoscopy With Cone CT and Indocyanine Green to Aid Removal of Lung Lesions in Patients With Stage I Non-small Cell Lung Cancer or Lung Metastases, REPLACING Study

Scroll to load more

Research Network

Activity Timeline